Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New findings in cancer vaccines described by M. Iero and co-researchers
June 3rd, 2009
New investigation results, 'Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity,' are detailed in a study published in Cancer Immunology, Immunotherapy. According to a study from Milan, Italy, "The discovery of tumor antigens recognized by T cells and the features of immune responses directed against them has paved the way to a multitude of clinical studies aimed at boosting anti-tumour T cell immunity as a therapeutic tool for cancer patients. One of the different strategies explored to ameliorate the immunogenicity of tumor antigens in vaccine protocols is represented by the use of optimized peptides or altered peptide ligands, whose amino...
Source: Vaccine Weekly (2009-06-03)
|
